Morphic Therapeutic has lost Johnson & Johnson's Janssen Pharma as a partner, following the termination of an alliance to develop drugs targeting integrins first agreed in 2019. In a filing with ...

Eli Lilly has bolstered its inflammatory bowel disease (IBD) pipeline with a $3.2 billion bid to acquire Morphic and its mid-stage oral integrin therapy MORF-057. Lilly is launching a tender offer ...

Once Humans Broken Delta holds many Morphic Crates. Use Spacetime powers to reveal and defeat their mimic guardians!

Morphic Holding, Inc. has a twelve month low of $19.34 and a twelve month high of $57.00. The company has a market capitalization of $2.85 billion, a PE ratio of -16.28 and a beta of 1.49.

Shares of biotech firm Morphic Holding, founded by Harvard immunologist Tim Springer, rocketed up 75% Monday after Eli Lilly said it would snap it up for $3.2 billion.

Eli Lilly’s Morphic acquisition brings an oral small molecule that blocks the same target as Entvyio, an injectable inflammatory bowel disease drug from Takeda Pharmaceutical. The Morphic deal ...

Learn every way in which you can earn the currency called Starchrom and what you can do with it in Once Human.

Tulisokibart is a tumor necrosis factor (TNF)-like cytokine 1A (TL1A) monoclonal antibody with a different mechanism of ...

Upgrade your Yahoo Finance plan to get complete details for Morphic Holding Inc. Get advanced tools and insights to navigate the markets.

This transformative shift reflects the evolving landscape of the industry and Morphic Medical's commitment to driving innovation in patient care. Since its inception, Morphic Medical has witnessed ...

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Morphic Ethical Equities Fund Limited (MEC). However, you won't necessarily see their names in ...